The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2Z)-2-{[1-(3-chlorophenyl)-3-(5-methoxy-1H-indol-3-yl)-1H-pyrazol-5-yl]imino}-1,3-thiazolidin-4-one ID: ALA5281502
Max Phase: Preclinical
Molecular Formula: C21H16ClN5O2S
Molecular Weight: 437.91
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2[nH]cc(-c3cc(/N=C4/NC(=O)CS4)n(-c4cccc(Cl)c4)n3)c2c1
Standard InChI: InChI=1S/C21H16ClN5O2S/c1-29-14-5-6-17-15(8-14)16(10-23-17)18-9-19(24-21-25-20(28)11-30-21)27(26-18)13-4-2-3-12(22)7-13/h2-10,23H,11H2,1H3,(H,24,25,28)
Standard InChI Key: TXMKVCJJUJONHS-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
0.0065 0.5702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8315 0.5702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0816 -0.2336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4281 -0.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2392 -0.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8782 -0.4471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0916 -1.2437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8883 -1.4572 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9217 -2.2982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1690 -2.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6518 -1.9360 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6360 -2.7106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0359 -0.4259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2493 -1.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0904 -1.2560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3758 -0.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7281 0.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1449 -0.2012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2693 0.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6260 1.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8529 0.8369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2438 1.2845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8316 1.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2435 2.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0684 2.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4801 2.0007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0721 1.2845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8395 1.9310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6360 2.1445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3048 2.0007 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
1 5 2 0
5 4 1 0
3 6 1 0
6 7 2 0
8 7 1 0
8 9 1 0
9 10 1 0
11 10 1 0
7 11 1 0
9 12 2 0
5 13 1 0
14 13 2 0
14 15 1 0
15 16 1 0
17 16 2 0
13 17 1 0
16 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
17 21 1 0
2 22 1 0
23 22 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
22 27 1 0
20 28 1 0
28 29 1 0
26 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.91Molecular Weight (Monoisotopic): 437.0713AlogP: 4.53#Rotatable Bonds: 4Polar Surface Area: 84.30Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.57CX Basic pKa: 0.88CX LogP: 4.54CX LogD: 4.31Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.49Np Likeness Score: -1.24
References 1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141 ] [10.1039/d2md00442a ]